LLY Jun 2024 790.000 put
OPR - OPR Delayed Price. Currency in USD
Add to watchlist
As of 03:55PM EDT. Market open.
| Previous Close | 0.1000 |
| Open | 0.0600 |
| Bid | 0.0000 |
| Ask | 0.1200 |
| Strike | 790.00 |
| Expire Date | 2024-06-07 |
| Day's Range | 0.0100 - 0.2600 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 159 |
- Yahoo Finance Video
FDA panel votes to recommend Eli Lilly's Alzheimer's drug
A US Food and Drug Administration (FDA) panel voted unanimously 11-0 to recommend the approval of Eli Lilly's (LLY) Alzheimer's drug, donanemab. Yahoo Finance's Anjalee Khemlani reports more on the story and the drug's ability to slow cognitive decline. Read more about donanemab here. For more expert insight and the latest market action, click here to watch this full episode of Market Domination. This post was written by Melanie Riehl
ZacksApple Joins A.I. Race; Lilly Thumbs-Up on Alzheimer's Drug
Considering how many Apple products there are out there in the world at this time, a high number of them will soon be accessing A.I. from an Apple device.
Investor's Business DailyFDA Panelists Unanimously Back Eli Lilly's Biogen-Rivaling Alzheimer's Drug
Eli Lilly stock jumped Monday after FDA advisors said the benefits of Alzheimer's treatment donanemab outweigh the risks for most patients.
© 2024 Yahoo. All rights reserved.